Biotech · Private company · San Carlos, CA, US
SonALAsense, Inc.
Track this companyFree. Adds SonALAsense, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)Phase 2 · Diffuse Intrinsic Pontine GliomaClinicalTrials.gov · fetched Nov 12, 2026
- SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)Phase 2 · Recurrent GBMClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBMPHASE1_PHASE2 · TERMINATED · started Feb 6, 2023ClinicalTrials.gov NCT05370508 · fetched Nov 12, 2026
- A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPGPHASE2 · SUSPENDED · started Aug 12, 2022ClinicalTrials.gov NCT05123534 · fetched Nov 12, 2026
- Study of Sonodynamic Therapy in Participants With Recurrent High-Grade GliomaEARLY_PHASE1 · TERMINATED · started Mar 15, 2021ClinicalTrials.gov NCT04559685 · fetched Nov 12, 2026
NIH awards2
- Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiformeFiscal year 2026 · $497.4KNIH RePORTER 5R44CA275508-03 · fetched Nov 12, 2026
- Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiformeFiscal year 2025 · $796.2KNIH RePORTER 5R44CA275508-02 · fetched Nov 12, 2026